That New Alzheimer ’s Drug? Don’t Get Your Hopes Up Yet

After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.

Source: NYT Health - October 22, 2019 Category: Consumer Health News Authors: Gina Kolata Tags: Alzheimer ' s Disease Drugs (Pharmaceuticals) Dementia Food and Drug Administration Biogen Source Type: news